Common use of Investigational Medicinal Product Clause in Contracts

Investigational Medicinal Product. The CRO shall ensure that the Principal Investigator be provided with the relevant quantities of the Investigational Medicinal Product necessary to perform the Clinical Trial, to be delivered to the Site pharmacy, where the Investigational Medicinal Product shall be documented, prepared and stored in accordance with the applicable laws and the Protocol. Neither the Site nor the Principal Investigator shall use the Investigational Medicinal Product for any other purpose except conducting the Clinical Trial. The Principal Investigator undertakes to only use the Investigational Medicinal Product in the manner specified in the Protocol. Once the Agreement expires or is terminated, the Site and the Principal Investigator shall immediately return any unused Investigational Medicinal Products to the CRO at the CRO’s cost and upon the Sponsor’s written instructions. Should the Investigational Medicinal Products supplied for the purposes of the Clinical Trial need to be disposed of, the CRO shall cover the relevant costs in accordance with the price list applicable at the Site and shall issue the necessary instructions.

Investigational Medicinal Product. The CRO shall ensure that the Principal Investigator be provided with the relevant quantities of the Investigational Medicinal Product necessary to perform the Clinical Trial, to be delivered to the Site pharmacy, where the Investigational Medicinal Product shall be documented, prepared and stored in accordance with the applicable laws and the Protocol. Neither the Site Institution nor the Principal Investigator shall use the Investigational Medicinal Product for any other purpose except conducting the Clinical Trial. The Principal Investigator undertakes to only use the Investigational Medicinal Product in the manner specified in the Protocol. Once the Agreement expires or is terminated, the Site Institution and the Principal Investigator shall immediately return any unused Investigational Medicinal Products to the CRO at the CRO’s cost and upon the Sponsor’s written instructions. Should the Investigational Medicinal Products supplied for the purposes of the Clinical Trial need to be disposed of, the CRO shall cover the relevant costs in accordance with the price list applicable at the Site Institution and shall issue the necessary instructions.